Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan 7;14(1):e0209217.
doi: 10.1371/journal.pone.0209217. eCollection 2019.

Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute

Affiliations

Ex vivo biophysical characterization of a hydrogel-based artificial vitreous substitute

Kai Januschowski et al. PLoS One. .

Abstract

Purpose: To characterize the biophysical properties of an artificial vitreous body substitute (VBS), which consists of a biocompatible, cross-linked, hyaluronic acid (HA)-based hydrogel, by analysing the VBS's influence on intraocular pressure (IOP) and retinal integrity in distinct ex vivo eye models in order to evaluate the its potential for in vivo biocompatibility testing.

Methods: Pig eyes were obtained immediately postmortem, and VBS was injected after core-vitrectomy. IOP was followed for 24 h (n = 5). VBS influence on retinal integrity was investigated using isolated bovine retinas superfused with an oxygen saturated nutrient solution. An electroretinogram (ERG) was recorded on explanted bovine retinae using silver/silver chloride electrodes; after application of VBS for 2 min, a washout period of 70 min was employed. The percentage of a-and b-wave reduction at the end of the washout phase was compared to baseline values (n = 5). Data were calculated throughout as the mean and the standard deviation. qRT-PCR (Bax/Bcl-2-ratio, GFAP- and PGP9.5-levels) or western blot analysis was used to test for toxicity of Princess Volume after 24 h (and β-3 tubulin with GAPDH as a control gene). Significance was estimated by Student´s t-test; p ≤0.05 was considered to be statistically significant.

Results: The IOP increased non-significantly by 10% after 24 h. Short-term biocompatibility testing using isolated superfused bovine retinas showed neither significant reductions of the b-wave nor the a-wave amplitudes (b-wave reduction 14.2%, p>0.05; a-wave reduction 23.9%, p>0.05). qRT-PCR and western blot analysis did not reveal significant toxicity after 24 h.

Conclusions: The manufactured HA-based hydrogel showed highly favourable biophysical characteristics in the explored ex vivo models, justifying in vivo studies enabling the assessment of biocompatibility.

PubMed Disclaimer

Conflict of interest statement

Parts of the experiments were financed by Croma Pharma GmbH, Austria. CH and CR are employed by Croma Pharma GmbH. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Overview of physicochemical characteristics of VBS.
The blue, red and green points represent the storage moduli, the cubes represent the loss moduli (20-gauge needle) and the triangles the elasticity.
Fig 2
Fig 2. Effects of VBS on the IOP in the porcine vitrectomy model.
Average of series (n = 5). Representative standard deviations for each measurement are given.
Fig 3
Fig 3. Effects of BSS serving as control on the IOP in the porcine vitrectomy model.
Average of series (n = 5). Representative standard deviations for each measurement are given.
Fig 4
Fig 4. Effects of VBS on the a- and b-wave amplitude of the ERG taken from isolated superperfused bovine retinae.
Average of series (n = 5). The blue line represents the a-wave amplitudes, the red line represents the b-wave amplitudes. Representative standard deviations for each drug series are given.

References

    1. Kleinberg TT, Tzekov RT, Stein L, Ravi N, Kaushal S. Vitreous substitutes: a comprehensive review. Survey of ophthalmology. [Review]. 2011. Jul-Aug;56(4):300–23. 10.1016/j.survophthal.2010.09.001 - DOI - PubMed
    1. Spitzer MS, Januschowski K. [Aging and age-related changes of the vitreous body]. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2015. July;112(7):552, 4–8. - PubMed
    1. Le Goff MM, Bishop PN. Adult vitreous structure and postnatal changes. Eye. [Review]. 2008. October;22(10):1214–22. 10.1038/eye.2008.21 - DOI - PubMed
    1. Suri S, Banerjee R. In vitro evaluation of in situ gels as short term vitreous substitutes. Journal of biomedical materials research Part A. 2006. December 1;79(3):650–64. 10.1002/jbm.a.30917 - DOI - PubMed
    1. Su X, Tan MJ, Li Z, Wong M, Rajamani L, Lingam G, et al. Recent Progress in Using Biomaterials as Vitreous Substitutes. Biomacromolecules. 2015. October 12;16(10):3093–102. 10.1021/acs.biomac.5b01091 - DOI - PubMed

Publication types